The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1/2a study of PBP1510 (anti-PAUF mAb) in advanced/metastatic pancreatic adenocarcinoma: Safety results from early combination cohorts.
 
Daniel King
Stock and Other Ownership Interests - Illumina
Honoraria - Ipsen; Omni Health; Omni Health; Skysis
Patents, Royalties, Other Intellectual Property - I am a joint author on iNav, a tool to computationally identify and navigate patients to cancer care.
 
David Tai
Consulting or Advisory Role - AstraZeneca; Eisai
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Ipsen; Roche
 
Jaime Feliú
Consulting or Advisory Role - Amgen; AstraZeneca; Roche/Genentech; Viatris
Research Funding - Amgen; Amgen
Travel, Accommodations, Expenses - Amgen
 
Jamie Kim
Employment - Prestige BioPharma
 
Kedar Diwakar Mandakhalikar
Employment - Prestige BioPharma
 
Mei Li Lim
Employment - Prestige BioPharma
 
Sumita Pradhan
Employment - Prestige BioPharma
 
Yun-Yong Park
Employment - Prestige BioPharma IDC Co,.Ltd